Skip to main content
. Author manuscript; available in PMC: 2012 Nov 17.
Published in final edited form as: Health Aff (Millwood). 2012 Apr;31(4):750–759. doi: 10.1377/hlthaff.2011.1062

Exhibit 1. Trends In Use Of IMRT Or Three-Dimensional Conformal Therapy For The Treatment Of Medicare Beneficiaries Diagnosed With Prostate Cancer, 2001–07.

Exhibit 1

SOURCE Authors’ analysis of linked Surveillance, Epidemiology, and End Results (SEER)-Medicare data. NOTES Among beneficiaries diagnosed with prostate cancer, there was an 87 percent decrease in the use of three-dimensional conformal therapy along with amore than 1,000 percent increase in the use of intensity-modulated radiotherapy (IMRT) from 2001 through 2007. Statistical significance denotes test for trend. ****p < 0:001